154 related articles for article (PubMed ID: 32608111)
1. Interactions between cannabidiol and Δ
Anderson LL; Low IK; McGregor IS; Arnold JC
Br J Pharmacol; 2020 Sep; 177(18):4261-4274. PubMed ID: 32608111
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome.
Anderson LL; Bahceci DA; Hawkins NA; Everett-Morgan D; Banister SD; Kearney JA; Arnold JC
PLoS One; 2023; 18(1):e0280842. PubMed ID: 36701411
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ
Javadzadeh Y; Santos A; Aquilino MS; Mylvaganam S; Urban K; Carlen PL
Cells; 2024 Mar; 13(6):. PubMed ID: 38534310
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery.
Del Pozo A; Barker-Haliski M
Exp Neurol; 2023 Feb; 360():114288. PubMed ID: 36471511
[TBL] [Abstract][Full Text] [Related]
6. Switching from zonisamide to perampanel improved the frequency of seizures caused by hyperthermia in Dravet syndrome: a case report.
Horiuchi K; Kudo A; Nakamura S; Yamada K; Inoue T; Fujii S; Oshima Y
J Med Case Rep; 2024 Jan; 18(1):3. PubMed ID: 38167335
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain.
Britch SC; Craft RM
J Pain; 2023 Jan; 24(1):98-111. PubMed ID: 36122809
[TBL] [Abstract][Full Text] [Related]
8. Δ
Hodges RM; Chase KJ; Tripson MA; Bingham S; Woolley-Roberts M; Guy GW; Soderstrom K
Cannabis Cannabinoid Res; 2023 Oct; 8(5):790-801. PubMed ID: 36125410
[No Abstract] [Full Text] [Related]
9. Anticonvulsant effect of equilibrative nucleoside transporters 1 inhibitor in a mouse model of Dravet syndrome.
Ho SY; Chen IC; Tsai CW; Chang KC; Lin CJ; Chern Y; Liou HH
Hippocampus; 2024 Jan; 34(1):7-13. PubMed ID: 37933097
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
Perucca E
J Epilepsy Res; 2017 Dec; 7(2):61-76. PubMed ID: 29344464
[TBL] [Abstract][Full Text] [Related]
11. Channelopathy of Dravet Syndrome and Potential Neuroprotective Effects of Cannabidiol.
Xu C; Zhang Y; Gozal D; Carney P
J Cent Nerv Syst Dis; 2021; 13():11795735211048045. PubMed ID: 34992485
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review.
Balachandran P; Elsohly M; Hill KP
J Gen Intern Med; 2021 Jul; 36(7):2074-2084. PubMed ID: 33515191
[TBL] [Abstract][Full Text] [Related]
13. Cell death induction and intracellular vesicle formation in human colorectal cancer cells treated with Δ
Hwang YN; Kwon IS; Park JH; Na HH; Kwon TH; Park JS; Kim KC
Genes Genomics; 2023 Dec; 45(12):1463-1474. PubMed ID: 37837516
[TBL] [Abstract][Full Text] [Related]
14. Effects of Chronic, Low-Dose Cannabinoids, Cannabidiol, Delta-9-Tetrahydrocannabinol and a Combination of Both, on Amyloid Pathology in the 5xFAD Mouse Model of Alzheimer's Disease.
Arnanz MA; Ruiz de Martín Esteban S; Martínez Relimpio AM; Rimmerman N; Tweezer Zaks N; Grande MT; Romero J
Cannabis Cannabinoid Res; 2023 Oct; ():. PubMed ID: 37862567
[No Abstract] [Full Text] [Related]
15. Absence of Age Verification for Online Purchases of Cannabidiol and Delta-8: Implications for Youth Access.
Egan KL; Villani S; Soule EK
J Adolesc Health; 2023 Jul; 73(1):195-197. PubMed ID: 36870900
[TBL] [Abstract][Full Text] [Related]
16. Subtype-specific modulation of human K
Pökl M; Sridhar A; Frampton DJA; Linhart VA; Delemotte L; Liin SI
Br J Pharmacol; 2023 Dec; 180(23):2956-2972. PubMed ID: 37377025
[TBL] [Abstract][Full Text] [Related]
17. Reefer to the Rescue: The Dope on Cannabidiol as a Multi-Symptom Panacea for Dravet Syndrome.
Gupta A; Santhakumar V
Epilepsy Curr; 2018; 18(2):118-120. PubMed ID: 29643753
[No Abstract] [Full Text] [Related]
18. Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome.
Lattanzi S; Zaccara G; Russo E; La Neve A; Lodi MAM; Striano P
Expert Rev Neurother; 2021 Jan; 21(1):99-110. PubMed ID: 33026899
[TBL] [Abstract][Full Text] [Related]
19. Development of cannabidiol as a treatment for severe childhood epilepsies.
Williams CM; Stephens GJ
Br J Pharmacol; 2020 Dec; 177(24):5509-5517. PubMed ID: 32986848
[TBL] [Abstract][Full Text] [Related]
20. Cannabis, More Than the Euphoria: Its Therapeutic Use in Drug-Resistant Epilepsy.
Buchanan-Peart KR; Oribhabor GI; Khokale RV; Nelson ML; Cancarevic I
Cureus; 2020 Jul; 12(7):e9299. PubMed ID: 32832296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
